HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Yaron Bar-El Zvi Adler Shtiwi Sawaed Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bar-El, Y. Articles by Milo, S. Search for Related Content PubMed PubMed Citation Articles by Bar-El, Y. Articles by Milo, S.

Eur J Cardiothorac Surg 1999;15:271-275
© 1999 Elsevier Science NL

Myocardial protection in operations requiring more than 2 h of aortic cross-clamping

Department of Cardiac Surgery, Rambam Medical Center, Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel

Received 14 September 1998; received in revised form 31 December 1998; accepted 12 January 1999.

Corresponding author. Tel.: +972-4-8542-631; fax: +972-4-8539-069; email: y_bar_el@rambam.health.gov.il

Objective: Long periods of aortic cross-clamping time during cardiac surgery are associated with high rates of morbidity and mortality because of damage to the myocardium. Recently, we have used a method of myocardial protection based on the principles of hyperkalemic cardioplegic arrest. We use antegrade administration of warm, undiluted blood followed by continuous retrograde infusion of tepid, undiluted blood supplemented with potassium and magnesium. In this study, we have retrospectively reviewed our experience with this method of cardioprotection in operations requiring more than 2 h of cross-clamp time. Methods: We retrospectively reviewed the medical records of 1280 patients who underwent myocardial revascularization, valve repair or replacement, or a combination of both operations between January 1, 1994 and December 31, 1997. Patients were divided into two groups: the short cross-clamp group (SXC) (n=1144) had cross-clamp times <120 min (mean, 78±20 min; range, 35–119 min) and the long cross-clamp group (LXC) (n=136) had cross-clamp times >120 min (mean, 154±31 min; range, 120–277 min). We compared preoperative, operative, and postoperative variables between the two groups. Results: Significantly more patients in the long cross-clamp group (43.4%) underwent the combined operation than in the short cross-clamp group (2.3%), and the rate of reoperation was significantly higher in the long cross-clamp group (12%) than in the short cross-clamp group (5%). Despite these differences in operative complexity, we found no difference in hospital mortality rates between the two groups. The only significant postoperative differences were that the long cross-clamp group had a greater need for inotropic agents (43 vs. 29%), higher serum levels of creatine kinase (880±583 vs. 613±418) and CK-MB (10.9±6.4 vs. 5.9±5.2), and a longer hospital stay (9.6 vs. 6.1 days). Conclusion: Long, complex operations requiring more than 2 h of cross-clamping can be performed safely with our method of cardioprotection based on continuous retrograde infusion of tepid, hyperkalemic, undiluted blood.

Key Words: Cardioplegia • Cardiac surgery • Myocardial protection • Creatine phosphokinase isoenzyme MB

This article has been cited by other articles:

				E. Bezon, J. N. Choplain, A. A. Aziz Khalifa, H. Numa, N. Salley, and J. A. Barra Continuous retrograde blood cardioplegia ensures prolonged aortic cross-clamping time without increasing the operative risk Interactive CardioVascular and Thoracic Surgery, August 1, 2006; 5(4): 403 - 407. [Abstract] [Full Text] [PDF]

				Y. Bar-El, B. Gilboa, N. Unger, D. Pud, and E. Eisenberg Skeletonized versus pedicled internal mammary artery: impact of surgical technique on post CABG surgery pain Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 1065 - 1069. [Abstract] [Full Text] [PDF]

				Y. Hayashi, Y. Sawa, N. Fukuyama, Y. Miyamoto, T. Takahashi, H. Nakazawa, and H. Matsuda Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic crossclamping for more than 120 minutes J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1813 - 1821. [Abstract] [Full Text] [PDF]

				F. Onorati, A. Renzulli, M. De Feo, G. Santarpino, R. Gregorio, A. Biondi, F. Cerasuolo, and M. Cotrufo Does antegrade blood cardioplegia alone provide adequate myocardial protection in patients with left main stem disease? J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1345 - 1351. [Abstract] [Full Text] [PDF]

				Y. Bar-El, A. Kophit, O. Cohen, and V. Kertzman Continuous retrograde cardioplegia simplifies aortic valve replacement in the presence of a patent internal mammary artery Ann. Thorac. Surg., October 1, 2003; 76(4): 1337 - 1338. [Full Text] [PDF]

				P. Suominen, R. Palo, H. Sairanen, K.T. Olkkola, and J. Rasanen Perioperative determinants and outcome of cardiopulmonary arrest in children after heart surgery Eur. J. Cardiothorac. Surg., February 1, 2001; 19(2): 127 - 134. [Abstract] [Full Text] [PDF]